Predictive Oncology Launches $344M DePIN Treasury

Predictive Oncology (POAI), a Nasdaq-listed biotech specializing in AI-driven cancer research, has announced a $344.4 million digital asset treasury centered on Aethir’s ATH token.

The move marks the first time a U.S.-listed company has built a treasury around a Decentralized Physical Infrastructure Network (DePIN) asset. Structured with support from DNA Fund and BTIG, the deal combined traditional PIPE financing with in-kind ATH token contributions, enabling Predictive Oncology to record decentralized assets on its balance sheet.

Aethir provides decentralized GPU infrastructure for AI, gaming, and high-performance computing, coordinated through blockchain technology. Its native token, ATH, trades below $0.06 but saw a 330% surge in 24-hour volume after the announcement, with a market cap of $2.3 billion.

This bold treasury strategy positions Predictive Oncology at the intersection of biotech innovation and decentralized infrastructure, potentially setting a precedent for how traditional firms approach DePIN integration.

You need to login in order to Like